Pharmaceutical Business Review Latest News News Archive
Latest news from Pharmaceutical Business Review
http://www.pharmaceutical-business-review.com/rss/rss_features.asp
Page: 1 of 40 
- McNeil to co-distribute Cephalon's ADHD drug
- GlaxoSmithKline acquires Wyeth's flu vaccine facility
- Biogen Idec and Genentech seek approval for Rituxan in arthritis
- Encouraging FDA report on Chiron factory
- Eisai requests expanded approval for Alzheimer's drug
- FDA gives clearance for GlaxoSmithKline's flu vaccine
- Forbes Medi-Tech seeks approval for cholesterol drug study
- Stem cells improve heart function in ViaCell test
- CytRx begins study into obesity gene
- StemCells gains license for cell processing facility
- MicroIslet and The Scripps Research Institute extend diabetes collaboration
- Novartis proposes takeover of Chiron
- BioCryst initiates trial into leukemia drug
- Aventis extends research collaboration with ImmunoGen
- FDA approves Tercica's growth disorder drug
- Early closure of trial for Vasogen's lead product
- Emergent typhoid vaccination performs well in test
- Momenta seeks FDA approval for generic Lovenox
- AmpliMed anticancer drug given expanded orphan status
- Cognetix neuropathic pain drug given orphan status
- Researchers discover why melanoma is so malignant
- Scientists develop fungus-fighting vaccine
- Researchers make breakthrough in neurological disorder
- Mutations in research stem cells uncovered by Affymetrix technology
- Study suggests strokes and heart attacks can be prevented
- Amgen initiates study into heart failure and anemia
- Adult stem cells from fat could save lives
- Positive data from Protein Design Labs heart failure study
- Positive results in study of VaxGen's smallpox vaccine
- FDA delays bone marrow drug
- Chiron rejects Novartis takeover offer
- EpiCept Corporation and Maxim Pharmaceuticals to merge
- Medtronic's drug-eluting stent system gets European approval
- Glaxo heart drug shown to be safer than rival
- Study highlights cost of new drugs
- More data needed for Bristol-Myers arthritis drug
- FDA allows late-stage BioAlliance antifungal trial
- Servier heart drugs get European backing
- King reports positive seven-year follow-up for cardiovascular drug
- Cytokinetics initiates trial of potential heart drug
- Teva and Barr to sell generic Allegra despite patent litigation
- Chemokine's SDF-1 analog improves quality of cord blood
- Spectrum commences new phase II study of bladder cancer drug
- pSivida and Cirrus to work together on new drug formulations
- Positive data from Geron liver and lung cancer trials published
- Labopharm gains European approval for once-daily painkiller
- Cipher receives regulatory blow over acne treatment
- Cephalon seeks FDA approval for cancer painkiller
- Kinex Pharmaceuticals selects compound for oncology development
- Nuvelo initiates phase III catheter occlusion study
- Study shows Genentech drug may be dangerous in combination with angioplasty
- MorphoSys and Centocor embark on new antibody project
- FDA approves Sanofi-Aventis' new sleeping pill
- GelStat Migraine proves effective against pain in first clinical trial
- Study shows AstraZeneca heart drug may prevent diabetes
- Pharmos tests safety of potential pain treatment
- Positive results for OncoGenex drug in early prostate cancer trial
- Avalon Pharmaceuticals seeks approval for cancer drug trial
- Knopp NeuroSciences secures license for neurodegenerative biomarkers
- Antares Pharma initiates phase II overactive bladder syndrome trial
- Celera Diagnostics and Merck extend Alzheimer's collaboration
- ImmunoGen initiates clinical bone marrow cancer trials
- Novartis and Alnylam form RNA interference alliance
- MediciNova completes enrollment for phase II asthma trial
- FDA committee backs Bristol-Myers Squibb arthritis drug
- FDA approves Merck & Co's combination child vaccine
- Avax seeks FDA approval for lung cancer drug trial
- Andrx drug applications in jeopardy following FDA inspection
- Hemispherx's drug boosts bird flu treatment in preclinical study
- MedImmune and VasGene form research collaboration
- GlycoGenesys cancer trial shows promise
- CytRx posts encouraging early results for HIV vaccine
- Indevus begins study of Sanctura XR bladder treatment
- Genaera receives patent covering aminosterol research method
- GlaxoSmithKline to buy ID Biomedical for $1.4 billion
- NeuroSolutions furthers development of Alzheimer's test
- Wyeth acquires license for use of Xoma's protein production technology
- FDA rejects fast track request for Genentech's Lucentis
- Pharmacyclics begins phase II trial of Xcytrin in lung cancer
- Columbia Labs advances possible dysmenorrhea treatment
- Caliper expands research potential with NovaScreen purchase
- Aeolus reports positive results from Lou Gehrig's drug study
- Oxxon's melanoma trial generates encouraging results
- Roche/Glaxo osteoporosis treatment approved in Switzerland
- Hana Biosciences initiates trial of anticancer compound
- Wyeth opens new biotech facility in Ireland
- Vical grants Merck rights to gene delivery technology
- Lilly/Alkermes'inhaled insulin generates encouraging phase II results
- ImClone licenses use of Mederex' antibody development system
- Stem cells show potential as post heart attack therapy
- Bayer and Onyx seek EU approval for kidney cancer drug
- FDA panel recommends BMS/Merck diabetes drug for approval
- Positive phase III trial results for Pain Therapeutics drug
- Biovail's pain medicine given final FDA approval
- Positive early study for Progenics' HIV drug
- FDA committee recommends approval of Pfizer and Sanofi-Aventis' Exubera
- King Pharmaceuticals and Inyx enter strategic alliance
- Introgen's anticancer drug demonstrates bystander effect in study
- Study reveals Takeda's diabetes drug reduces heart attacks
- Transition Therapeutics diabetes trial underway